Basal and Post-Methionine Serum Homocysteine and Lipoprotein Abnormalities in Patients with Chronic Liver Disease

Abstract

In contrast to previous reports, the site of the methionine metabolic impairment was found to be below the homocysteine synthesis level. For most patients with CLD, factors other than serum homocysteine or Lp(a) are responsible for the reduction in the risk of coronary heart disease. Further studies with larger samples are needed.